Title : Combination of linagliptin and metformin for the treatment of patients with type 2 diabetes.

Pub. Date : 2015

PMID : 25628514






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Addition of the dipeptidyl peptidase-4 inhibitor linagliptin, with its proven efficacy, low propensity for hypoglycemia, and weight neutrality, has been shown to improve glycemic control for patients who are not well controlled with metformin. Metformin dipeptidyl peptidase 4 Homo sapiens